KCAS-blog-thumb_2023_Biologics Blogs
Read article Addressing Bioanalytical Challenges in Biologics

Biologics are drugs derived from complex molecules like antibodies. Over the last two decades they have re-emerged…

Small_Moll Blogs
Read article Cell Sorting in Molecular Biology

As with the lineup of equine subjects above, cell populations can take similar forms and act the same in a lot of ways – but to the trained eye, there are clear…

KCAS-blog-thumb_2023_Navigating-Growth Blogs
Read article KCAS Bio Growth: Expanding with Scientific Integrity and Team Engagement

Clinical research carries significant risks and numerous obstacles that must be overcome to achieve success. Identifying the ideal Contract…

KCAS-blog-thumb_2023-03_neuro-diseases Blogs
Read article Therapeutic Efficacy in Neurodegenerative Disorders​

Neurodegenerative diseases affect millions worldwide. Fifty million people are living with Alzheimer’s disease or other dementias. Although Alzheimer’s disease is one of the most recognized, it is just one of many neurological disorders, such as Multiple Sclerosis, Parkinson’s, or Huntington’s disease. These conditions lead to a…

PATTERN_AMBER_1320x780_3 Blogs
Read article The ICH M10 Guideline as the Gold Standard

ICH M10 (International Committee of Harmonization Multidisciplinary guideline) provides guidance on bioanalytical method validation and study sample analysis for the measurement of chemical and biological human drugs and their metabolites in biological samples. Such pharmacokinetic/toxicokinetic data serve as the basis for regulatory decisions on the safety, dosage, and…

KCAS-blog-thumb_2023_kcas-flow-for-cgt Blogs
Read article Molecular Bioanalysis for Cell and Gene Therapies

Being that it is a relatively “niche” segment of the industry, there are several key areas that need to be considered in the field of molecular services related to cell and gene therapies. First and foremost, it is important to recognize that regulatory guidelines within this field are…

KCAS-blog-thumb_2023_02-KCAS-ADCs-with-Hybrid Blogs
Read article Antibody Drug Conjugate Services (ADC) Bioanalytical Services: Hybrid LC-MS & LBA Technology Solutions

Anyone who has been following KCAS for any amount of time has likely heard us discuss the advantages of Hybrid LC-MS/MS for the bioanalysis of large molecules. As pioneers in the technology for many years, KCAS has become a strong proponent of working with our customers to demonstrate the…

KCAS-blog-thumb_2023_01-B_Viral-Vectors-1 Blogs
Read article The Role of Bioanalysis in Viral Vector Development

In 2022 we had 42 FDA Drug Approvals and 3 were Gene Therapies using a viral vector.  2 of the approvals in 2022 were AAV based.  The third is manufactured by adding functional copies of the transgene to the patient’s own Hematopoietic Stem Cells (HSCs)…

KCAS-blog-thumb_2022_GLP-CGT Blogs
Read article The Role of GLP Toxicology Studies in Bioanalysis for CGT

Cell and Gene Therapies (CGTs) has an estimated market size value in 2022 of USD 8.22 billion and a revenue forecast in 2030 of USD 24.5 billion. This is a CAGR (compound annual growth rate) of 14.6% from 2022 to 2030. Needless to say, the…

KCAS-blog-thumb_2022_immunophenotyping-1 Blogs
Read article Flow Cytometry Services: Immunophenotyping

Due to its ability to analyze multiple parameters across different cell types within a sample, flow cytometry provides rich and clinically valuable data sets from even small volumes of blood. However, flow cytometry is a challenging platform to master, and requires significant investment in equipment and technical training.

KCAS-blog-thumb_2022_CSK-World-Class-Service Blogs
Read article Global Clinical Sample Logistics

KCAS established our Clinical Sample Kitting team in the early 1990s in response to shortcomings we observed in the collection techniques in trials where we were providing bioanalytical support. As the group has evolved, our aim has been to provide the flexible, custom service that…